How To Stop COVID-19 From Derailing Your Retirement
Justin Kuepper
|
Let’s take a look at a few key pieces of advice to stop...
Welcome to MutualFunds.com
Please help us personalize your experience and select the one that best describes you.
Your personalized experience is almost ready.
Thank you!
Check your email and confirm your subscription to complete your personalized experience.
Thank you for your submission
We hope you enjoy your experience
The company reported earnings of $1.835 billion, or $1.79 per share, up from $55.4 million, or 6 cents per share, last year. Analysts expected to see EPS of 7 cents.
Revenue
Revenue increased to $6.85 billion from $6.60 billion last year. Analysts expected to see revenue of $6.80 billion.
Outlook
Looking ahead, RAD expects to see FY2016 EPS between 19 cents and 27 cents.
Like other drug companies, Rite Aid is expanding its pharmacy and wellness business to boost sales. During the quarter, prescription sales grew 3.5%; this business segment accounted for 68.1% of total sales.
Symbol | Mutual Fund | Stake |
---|---|---|
RPMGX | T. Rowe Price Mid-Cap Growth | 2.80% |
PRHSX | T. Rowe Price Health Sciences | 2.31% |
NAESX | Vanguard Small Cap Index | 1.81% |
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Receive email updates about best performers, news, CE accredited webcasts and more.
Justin Kuepper
|
Let’s take a look at a few key pieces of advice to stop...
News
Iuri Struta
|
Most equities have continued their rally these past two weeks, along with investment-grade...
Aaron Levitt
|
While tax-gains harvesting takes some planning to implement, it can help save investors...
Find out why $30 trillon is invested in mutual funds.
Download our free report
Find out why $30 trillon is invested in mutual funds.
Download our free report
Find out why $30 trillon is invested in mutual funds.
Mutual Fund Education
Justin Kuepper
|
Let's take a closer look at how ESG investments have outperformed during the...
Mutual Fund Education
Daniel Cross
|
While CITs and mutual funds share many similarities, there are some key differences...
Mutual Fund Education
Sam Bourgi
|
The phrase ‘bear market’ has been thrown around a lot lately, but it...
The company reported earnings of $1.835 billion, or $1.79 per share, up from $55.4 million, or 6 cents per share, last year. Analysts expected to see EPS of 7 cents.
Revenue
Revenue increased to $6.85 billion from $6.60 billion last year. Analysts expected to see revenue of $6.80 billion.
Outlook
Looking ahead, RAD expects to see FY2016 EPS between 19 cents and 27 cents.
Like other drug companies, Rite Aid is expanding its pharmacy and wellness business to boost sales. During the quarter, prescription sales grew 3.5%; this business segment accounted for 68.1% of total sales.
Symbol | Mutual Fund | Stake |
---|---|---|
RPMGX | T. Rowe Price Mid-Cap Growth | 2.80% |
PRHSX | T. Rowe Price Health Sciences | 2.31% |
NAESX | Vanguard Small Cap Index | 1.81% |
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Receive email updates about best performers, news, CE accredited webcasts and more.
Justin Kuepper
|
Let’s take a look at a few key pieces of advice to stop...
News
Iuri Struta
|
Most equities have continued their rally these past two weeks, along with investment-grade...
Aaron Levitt
|
While tax-gains harvesting takes some planning to implement, it can help save investors...
Find out why $30 trillon is invested in mutual funds.
Download our free report
Find out why $30 trillon is invested in mutual funds.
Download our free report
Find out why $30 trillon is invested in mutual funds.
Mutual Fund Education
Justin Kuepper
|
Let's take a closer look at how ESG investments have outperformed during the...
Mutual Fund Education
Daniel Cross
|
While CITs and mutual funds share many similarities, there are some key differences...
Mutual Fund Education
Sam Bourgi
|
The phrase ‘bear market’ has been thrown around a lot lately, but it...